SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

20/20 To Air 'Justice For Faith' Friday, Oct. 30
On Sept. 7, 2012, University of North Carolina sophomore Faith Hedgepeth was found murdered in her off-campus apartment, leaving her family and friends devastated and...
Fri Oct 30, 2026

UNC graduate student took data science to the hardwood
As an undergraduate student at North Carolina, Boris Crnjak homed in on statistics and data science as his fields of study. “I’ll figure out the...
Thu Oct 29, 2026

Video: Carolina Calling - Eric Church Interview
Tommy Ashley and Joey Powell of inside Carolina speak with Tar Heel super-fan and 11-time Grammy nominee Eric Church about the Bill Belichick experiment in...
Tue Oct 27, 2026

Former UNC student Faith Hedgepeth's killer sentenced to life in prison without parole
A jury found Miguel Salguero-Olivares guilty of first-degree murder, first-degree rape, first-degree sexual offense, and first-degree burglary in the killing of UNC student Faith Hedgepeth...
Sat Oct 24, 2026